© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
BlackRock Science and Technology Trust (BST) stock declined over -5.86%, trading at $47.40 on NYSE, down from the previous close of $50.35. The stock opened at $47.92, fluctuating between $47.32 and $48.12 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 47.92 | 48.12 | 47.32 | 47.40 | 129.52K |
| Sep 14, 2026 | 49.64 | 50.41 | 49.46 | 50.35 | 172.04K |
| Sep 11, 2026 | 50.17 | 50.92 | 50.00 | 50.33 | 91.95K |
| Sep 10, 2026 | 49.29 | 50.11 | 49.28 | 49.55 | 125.46K |
| Sep 09, 2026 | 50.50 | 51.21 | 50.16 | 50.29 | 105.98K |
| Sep 08, 2026 | 50.80 | 51.11 | 50.61 | 50.81 | 110.6K |
| Sep 04, 2026 | 49.99 | 50.76 | 49.76 | 50.76 | 48.7K |
| Sep 03, 2026 | 50.23 | 50.51 | 49.67 | 49.86 | 106.23K |
| Sep 02, 2026 | 50.23 | 50.65 | 50.18 | 50.21 | 46.35K |
| Sep 01, 2026 | 50.68 | 50.68 | 50.18 | 50.36 | 77.27K |
| Aug 31, 2026 | 50.89 | 50.95 | 50.69 | 50.86 | 101.92K |
| Aug 28, 2026 | 50.98 | 51.22 | 50.63 | 50.81 | 89.81K |
| Aug 27, 2026 | 50.04 | 50.87 | 49.80 | 50.70 | 80.23K |
| Aug 26, 2026 | 49.37 | 49.90 | 49.34 | 49.67 | 69.2K |
| Aug 25, 2026 | 49.36 | 49.88 | 49.07 | 49.55 | 69.07K |
| Aug 24, 2026 | 49.45 | 49.46 | 48.99 | 49.01 | 58.29K |
| Aug 21, 2026 | 49.19 | 49.86 | 49.19 | 49.57 | 64.58K |
| Aug 20, 2026 | 48.56 | 49.40 | 48.56 | 49.19 | 45.53K |
| Aug 19, 2026 | 49.62 | 49.77 | 48.76 | 48.89 | 61.96K |
| Aug 18, 2026 | 49.85 | 50.00 | 49.40 | 49.43 | 91.07K |
New York City, NY 10001
United States
https://www.blackrock.com/us/individual/products/308764/science-and-technology-trust-ii-class212 810 5300The BlackRock Science and Technology Trust operates as a closed-end equity fund, established by BlackRock, Inc. Its management is overseen by BlackRock Advisors, LLC. The trust employs an investment strategy that involves both direct equity acquisitions and indirect exposure through derivatives, such as options, across public markets globally. It primarily targets companies operating within the scientific and technological sectors. The fund strategically allocates capital to both dividend-yielding and growth-oriented stocks, irrespective of their market capitalization. Inaugurated on October 28, 2014, the Trust is domiciled in the United States.
| Employees | 0 |
| Beta | 1.37 |
| Sales or Revenue | $291.28M |
| 5Y Sales Change% | 1.595% |
| Fiscal Year Ends | December |
| Sector | Financial Services |
| Industry | Asset Management |